Duration of androgen suppression in the treatment of prostate cancer
- Resource Type
- Authors
- Bolla, M; de Reijke TM; Van Tienhoven, G; Van den Bergh AC; Oddens, J; Poortmans, Pm; Gez, E; Kil, P; Akdas, A; Soete, G; Kariakine, O; van der Steen Banasik EM; Musat, E; Piérart, M; Mauer, Me; Collette, L.; EORTC Radiation Oncology Group; de Reijke TM, Genito Urinary Tract Cancer G. r. o. u. p.; van Tienhoven, G; van den Bergh AC; van Andel, G; van de Beek, C; Schimmel, E; Descotes, Jl; Bosset, Jf; Hay, Mh; Bachaud, Jm; Maingon, P; Courdi, A; Barillot, I; Carrie, C; Rothe Thomas, F; Lekili, M; van Poppel, H; Vekemans, K; Van Houtte, P; Verbaeys, A; Hoekx, L; Cutajar, Cl; Mirimanoff, R; Magrini, Stefano Maria; Busetto, M; Bono, A; Villa, S; Arribas, L; Maldonado, X; Kynaston, H; Barber, J; Saxby, M; Obralic, N.
- Source
- Subject
- Language
- English